Biweekly CHOP biweekly THP-COP regimen in the treatment of aggressive non-Hodgkin's lymphoma - Comparison of doxorubicin and pirarubicin: A randomized phase II study.

被引：0
|
作者：
Tsurumi, H
Sawada, M
Yamada, T
Hara, T
Goto, H
Fukuno, K
Shimizu, M
Yoshikawa, T
Kanemura, N
Takahashi, T
Oyama, M
Ozawa, K
Moriwaki, H
机构：
[1] Gifu Univ, Sch Med, Dept Internal Med 1, Gifu 500, Japan
[2] Kisogawa Hosp, Dept Internal Med, Kisogawa, Aichi, Japan
[3] Takayama Red Cross Hosp, Dept Internal Med, Takayama, Gifu, Japan
[4] Gifu Municipal Hosp, Dept Hematol, Gifu, Japan
[5] Jichi Med Sch, Dept Hematol, Minami Kawachi, Tochigi 32904, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1460
引用
收藏
页码：346A / 346A
页数：1
相关论文
共 50 条
  • [41] Results of treatment with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) for non-Hodgkin's aggressive lymphoma analyzed according to the International Prognostic Index
    Aydin, F
    Ulusoy, S
    Ovali, E
    [J]. JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 446 - 451
  • [42] CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis)
    Magnus, Bjorkholm
    Tomas, Andersson
    Anders, Ahlbom
    Eva, Osby
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (06) : 477 - 482
  • [43] High dose CHOP: A phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and leukemia group B 9351
    Peterson, Bruce A.
    Johnson, Jeffrey
    Shipp, Margaret A.
    Barcos, Maurice
    Gockerman, Jon P.
    Canellos, George P.
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (05) : 870 - 880
  • [44] Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial
    Jo, Jae-Cheol
    Baek, Jin Ho
    Lee, Je-Hwan
    Joo, Young-Don
    Bae, Sung-Hwa
    Lee, Jung-Lim
    Lee, Jung-Hee
    Kim, Dae-Young
    Lee, Won-Sik
    Ryoo, Hun Mo
    Choi, Yunsuk
    Kim, Hawk
    Lee, Kyoo-Hyung
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (02) : 159 - 166
  • [45] A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: A British national lymphoma investigation report
    Linch, DC
    Hudson, BV
    Hancock, BW
    Hoskin, PJ
    Cunningham, DC
    Newland, AC
    Milligan, DW
    Stevenson, PA
    Wood, JK
    MacLennan, KA
    Anderson, L
    Gregory, WM
    Hudson, GV
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (02) : 318 - 322
  • [46] Sphingosomal vincristine in CHOP +/- rituximab is a promising new treatment for patients with high risk untreated aggressive non-hodgkin's lymphoma (NHL): Follow-up results of a phase II study.
    Rodriguez, MA
    Sarris, A
    Dang, NH
    Fayad, L
    Goy, A
    Hagemeister, F
    McLaughlin, P
    Pro, B
    Romaguera, J
    Samaniego, F
    Younes, A
    Cabanillas, F
    [J]. BLOOD, 2004, 104 (11) : 234B - 234B
  • [47] Long-term follow-up in aggressive non-Hodgkin's lymphoma (NHL) patients treated with rHuG-CSF(lenograstim) combined biweekly CHOP chemotherapy.
    Dan, K
    Ogura, M
    Oyama, A
    Asano, S
    [J]. BLOOD, 2001, 98 (11) : 344A - 344A
  • [48] Comparison between chemotherapy regimens CHOP vs CHOP/VIA for the treatment of aggressive non-Hodgkin's lymphomas. Randomized multicenter study on 132 patients
    Lopez-Guillermo, A
    Garcia-Conde, J
    Alvarez-Carmona, AM
    Leon, P
    Maldonado, J
    Alcala, A
    Zubizarreta, A
    Sancho-Tello, R
    Carbonell, F
    Contreras, E
    Besses, C
    Hernando, A
    Fontanillas, M
    Montserrat, E
    [J]. MEDICINA CLINICA, 1998, 110 (16): : 601 - 604
  • [49] A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma
    Pangalis, GA
    Vassilakopoulos, TP
    Michalis, E
    Roussou, P
    Vrakidou, E
    Repousis, P
    Angelopoulou, MK
    Siakantaris, MP
    Korantzis, J
    Symeonidis, A
    Grigorakis, V
    Stefanoudakis, E
    Stamatellou, M
    Bourantas, KL
    Kalmantis, T
    Christopoulos, G
    Kokkinis, G
    Mihalakeas, I
    Papayiannis, A
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (04) : 635 - 644
  • [50] A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma
    Tulpule, A
    Khan, AU
    Mohrbacher, AF
    Espina, BM
    Buchanan, L
    Berman, N
    Gorospe, G
    Boswell, WD
    Nathwani, BN
    Levine, AM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 604S - 604S
12345